These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7896789)

  • 21. Expression and characterization of human factor IX and factor IX-factor X chimeras in mouse C127 cells.
    Lin SW; Smith KJ; Welsch D; Stafford DW
    J Biol Chem; 1990 Jan; 265(1):144-50. PubMed ID: 2294100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation.
    Lawson JH; Mann KG
    J Biol Chem; 1991 Jun; 266(17):11317-27. PubMed ID: 2040636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
    Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
    J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The activation of human factor IX.
    Osterud B; Laake K; Prydz H
    Thromb Diath Haemorrh; 1975 Jun; 33(3):553-63. PubMed ID: 239460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue factor-dependent activation of tritium-labeled factor IX and factor X in human plasma.
    Morrison SA; Jesty J
    Blood; 1984 Jun; 63(6):1338-47. PubMed ID: 6722352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a factor IX variant with a glycine207 to glutamic acid mutation.
    Lin SW; Lin CN; Hamaguchi N; Smith KJ; Shen MC
    Blood; 1994 Sep; 84(6):1866-73. PubMed ID: 7915915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of 125I-factor IX and 125I-factor X: effect of tissue factor and factor VII, factor Xa and thrombin.
    Osterud B; Rapaport SI
    Scand J Haematol; 1980 Mar; 24(3):213-26. PubMed ID: 7375819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X.
    Mathur A; Zhong D; Sabharwal AK; Smith KJ; Bajaj SP
    J Biol Chem; 1997 Sep; 272(37):23418-26. PubMed ID: 9287357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnesium(II) is a crucial constituent of the blood coagulation cascade. Potentiation of coagulant activities of factor IX by Mg2+ ions.
    Sekiya F; Yoshida M; Yamashita T; Morita T
    J Biol Chem; 1996 Apr; 271(15):8541-4. PubMed ID: 8621478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A monoclonal antibody to factor IX that inhibits the factor VIII:Ca potentiation of factor X activation.
    Bajaj SP; Rapaport SI; Maki SL
    J Biol Chem; 1985 Sep; 260(21):11574-80. PubMed ID: 3930478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathways in the activation of human coagulation factor X.
    Mertens K; Bertina RM
    Biochem J; 1980 Mar; 185(3):647-58. PubMed ID: 6770848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor X-activating glycoprotein of Russell's viper venom. Polypeptide composition and characterization of the carbohydrate moieties.
    Gowda DC; Jackson CM; Hensley P; Davidson EA
    J Biol Chem; 1994 Apr; 269(14):10644-50. PubMed ID: 8144654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX.
    Mertens K; van Wijngaarden A; Bertina RM
    Thromb Haemost; 1985 Oct; 54(3):654-60. PubMed ID: 3937263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbohydrate residues modulate the activation of coagulation factor X.
    Sinha U; Wolf DL
    J Biol Chem; 1993 Feb; 268(5):3048-51. PubMed ID: 8428982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.
    Zhong D; Smith KJ; Birktoft JJ; Bajaj SP
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3574-8. PubMed ID: 8170949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circadian rhythms of blood clotting time and coagulation factors II, VII, IX and X in rats.
    Soulban G; Labrecque G
    Life Sci; 1989; 45(25):2485-9. PubMed ID: 2607889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro mutagenesis study of two critical glutamic acids in the calcium binding loop of the factor IX heavy chain.
    Hamaguchi N; Stafford D
    Thromb Haemost; 1994 Dec; 72(6):856-61. PubMed ID: 7740454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme.
    Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K
    J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Components and assembly of the factor X activating complex.
    Ahmad SS; Rawala-Sheikh R; Walsh PN
    Semin Thromb Hemost; 1992; 18(3):311-23. PubMed ID: 1455249
    [No Abstract]   [Full Text] [Related]  

  • 40. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
    Osterud B; Kasper CK; Lavine KK; Prodanos C; Rapaport SI
    Thromb Haemost; 1981 Feb; 45(1):55-9. PubMed ID: 7245126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.